Browsing by Author "Henning, Laura M."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Article Targeted multidrug delivery systems to kill antibiotic-resistant Staphylococcus aureus(Journal of Drug Delivery Science and Technology, 2023-10-01) Özalp, Veli Cengiz; Uçak, Samet; Dursun, Ali D.; Sudağıdan, Mert; İçin, Öykü; Vakifahmetoglu, Çekdar; Henning, Laura M.; Simon, Ulla; Gurlo, AleksanderDifferent ordered mesoporous silica (OMS) nanoparticles, ranging from regular COK-12 to COK-12 modified in terms of pore shape and size, have been employed as standard drug carriers for the controlled adsorption and release of drug molecules in comparison to well known OMS SBA-15 and MCM-41. The cytotoxicity analysis demonstrated that regular COK-12 particles were less harmful to mammalian cultured cells, causing lower apoptosis induction than modified COK-12, MCM-41, and SBA-15 particles. Thus, regular COK-12 was further used to prepare a dual antibiotic-loaded drug delivery material, followed by surface functionalization with Staphylococcus aureus-specific aptamers for targeting. The results demonstrated that the joint loading of lysozyme and vancomycin in regular COK-12 improved the ability of the antibiotic treatments to kill methicillin-resistant Staphylococcus strains via aptamer targeting. The minimum inhibitory concentration (MIC) values decreased 4.1-fold and 12-fold compared to the non-targeted use of the antimicrobial agents in homogeneous solutions for vancomycin and lysozyme, respectively, clearly demonstrating the high potential of COK-12 to be used as a carrier in multidrug therapy.